Microbial contamination introduces protein-degradation enzymes that ruin the vial overnight
That decline tracks with a lot of what we associate with aging: slower wound healing, thinner skin, and yes, hair loss
Independent replication by Western researchers is limited
Topline data from the Phase 3 REDEFINE 1 trial found CagriSema, a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved superior weight loss versus placebo in adults with 1 Announced by Novo Nordisk on December 20, 2024, the trial achieved its primary endpoint with a superior weight loss of 22.7% after 68 weeks of treatment but still fell short of the 25% weight loss expected by the company in earlier discussions
A 503A pharmacy follows the traditional patient-specific compounding model and is primarily overseen through state pharmacy regulation, with federal law also applying
Final Check: Ensure there are no clumps or particles left before storing the vial in the refrigerator